Diazoxide Choline Extended-Release Tablet in People with Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.

Jennifer L MillerEvelien GeversNicola BridgesJack A YanovskiParisa SalehiKathryn S ObrynbaEric I FelnerLynne M BirdAshley H ShoemakerMoris AnguloMerlin G ButlerDavid StevensonJennifer AbuzzahabTimothy BarrettMelissa LahElizabeth LittlejohnVerghese MathewNeil M CowenAnish Bhatnagar

Published in: The Journal of clinical endocrinology and metabolism (2023)

DCCR did not significantly improve hyperphagia in the primary analysis but did in participants with severe baseline hyperphagia and in the Pre-COVID analysis. DCCR treatment was associated with significant improvements in body composition and clinician reported outcomes.

Keyphrases

body composition
sars cov
resistance training
early onset
clinical trial
type diabetes
metabolic syndrome
insulin resistance
growth hormone
high intensity
drug induced
smoking cessation
respiratory syndrome coronavirus